Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
AnHeart Therapeutics acquisition by Nuvation Bio
We are advising AnHeart Therapeutics on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
GSK exclusive license agreement for HS-20093 with Hansoh Pharma
We advised GSK on the transaction
Smith+Nephew acquisition of CartiHeal
We are advising Smith+Nephew on the acquisition
Forbion European Acquisition $138 million combination with enGene
We advised Forbion European Acquisition on its de-SPAC transaction
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction